title: Re: Development of a doxazosin and finasteride transdermal system for combination therapy of benign prostatic hyperplasia.
authors.forename: Steven A
authors.initials: SA
authors.lastname: Kaplan
mesh_terms: D058891:5-alpha Reductase Inhibitors / Q000008:administration & dosage*; D058668:Adrenergic alpha-1 Receptor Antagonists / Q000008:administration & dosage*; D000818:Animals; D017292:Doxazosin / Q000008:administration & dosage*; D018120:Finasteride / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D014677:Pharmaceutical Vehicles / Q000378:metabolism*
chemical_list: D058891:5-alpha Reductase Inhibitors; D058668:Adrenergic alpha-1 Receptor Antagonists; D014677:Pharmaceutical Vehicles; D018120:Finasteride; D017292:Doxazosin